Table 1 AML patient characteristics.

From: Induction of NK cell reactivity against acute myeloid leukemia by Fc-optimized CD276 (B7-H3) antibody

 

Number of patients (n = 68)

Age at diagnosis [years]

61.7 (range 26.0–89.0)

Sex [%]

 Female

48.5 (33)

 Male

51.5 (35)

Primary/Secondary AML [%]

 Primary

77.9 (53)

 Secondary

14.7 (10)

 Unknown

7.4 (5)

FAB classification [%]

 M0

4.4 (3)

 M1

25.0 (17)

 M2

22.1 (15)

 M3

0 (0)

 M4

19.1 (13)

 M5

25.0 (17)

 Unknown

4.4 (3)

Blood count at diagnosis

 PBB [%]

74.2 (range 2.0–100.0)

 WBC [G/L]

123.6 (range 2.2–448.3)

 Hb [g/dL]

8.5 (range 3.8–13.2)

 Plt [G/L]

69.2 (range 6.0–433.0)

  1. FAB French-American-British, PBB Peripheral Blood Blast, WBC White blood cells, Hb Hemoglobin, Plt Platelets.